Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

9:13 AM ET 8-K
Loan & Debt Federal Home Loan Bank of Indianapolis

Federal Home Loan Bank of Indianapolis $468M Debt Financing

The Federal Home Loan Bank of Indianapolis announced it has become the primary obligor for $467.79 million in consolidated obligation bonds. The debt issuance consists of five tranches with maturities ranging from April 2028 to September 2033 and includes both fixed-rate and variable-rate instruments.

Value
$468M
Term
through Sep 2033
9:13 AM ET 8-K
Leadership Change Blackberry Ltd BB

Blackberry Leadership Change

BlackBerry Limited has appointed David Chaikof, a legal veteran and investment executive, to its Board of Directors as an independent director. Mr. Chaikof previously served as external counsel to the company for over a decade and currently serves as a Senior Strategic Advisor at Osmington Inc. His appointment increases the board size to nine directors, eight of whom are independent.

9:11 AM ET 8-K
Nasdaq/NYSE Compliance Notice Ip Strategy Holdings, Inc. IPST

Ip Strategy Holdings Nasdaq/NYSE Compliance Notice

IP Strategy Holdings, Inc. has regained compliance with Nasdaq Listing Rule 5250(c)(1) following the filing of its delayed Quarterly Report on Form 10-Q for the period ended June 30, 2026. Nasdaq had previously issued a deficiency notice on August 26, 2026, due to the late filing, but has now confirmed the matter is closed.

Counterparty
The Nasdaq Stock Market LLC
9:08 AM ET 8-K
Contract Win Bridger Aerospace Group Holdings, Inc. BAER

Bridger Aerospace Group Holdings Wins $183M Contract from Bridgeporth Ltd.

Bridger Aerospace entered into a material aircraft services agreement with Bridgeporth Ltd. (a subsidiary of Metatek-Group Ltd.) to provide modification, maintenance, and operational services for a fleet of three Basler BT-67 aircraft. The agreement has an initial five-year term per aircraft with a five-year renewal option and an estimated total revenue potential of up to $183 million. This deal represents a strategic shift for Bridger to diversify its revenue streams beyond seasonal aerial firefighting into year-round global geophysical survey support.

Value
$183M
Counterparty
Bridgeporth Ltd.
Term
5 years
9:05 AM ET 8-K
Financial Results Cf Bankshares Inc. CFBK

Cf Bankshares Financial Results

CF Bankshares Inc. reported Q3 2026 net income of $6.0 million ($0.91 per diluted share) and a return on average equity of 12.22%. The company saw net interest margin expansion to 2.96% and strong commercial loan fundings totaling $79 million for the quarter.

Term
Q3 2026

“We had strong net income of $6.0 million for the third quarter, which was net of $551,000 of provision expense. Return on Equity (ROE) topped 12% at 12.22%, while our NIM expanded by 3 bps to 2.96%.”

Timothy T. O’Dell, President and CEO

“Looking ahead, we expect our rate of Growth to continue accelerating. As we deploy more available capital to work into Loan relationships, we see enhanced Earnings growth opportunity.”

Timothy T. O’Dell, President and CEO
9:03 AM ET 8-K
Financial Results Lincoln Electric Holdings Inc LECO

Lincoln Electric Holdings Financial Results

Lincoln Electric reported third quarter 2026 net sales of $1,221.3 million, a 15.1% increase driven by strong organic volume growth. Adjusted EPS rose 21% to $2.98, while the company also announced a 10.1% increase in its quarterly cash dividend to $0.87 per share.

Term
Q3 2026

“We achieved strong third quarter results led by higher volumes, an increase in our adjusted operating income margin, and record adjusted earnings per share. Our performance underscores the agility of our global team who are focused on supporting customers, diligently managing inflationary headwinds, and accelerating RISE strategy initiatives and investments to optimize long-term value for all our stakeholders.”

Steven B. Hedlund, Chairman and Chief Executive Officer
9:03 AM ET 10-Q
Financial Results Dorman Products, Inc. DORM ▶ Call

Dorman Products Q3 2026 Results: Net Income $59.2M, Down 22.6% YoY

Dorman Products reported net sales of $561.7 million for the third quarter of 2026, a slight increase from $543.7 million in the prior year, though net income decreased to $59.2 million from $76.4 million. The company significantly improved its operating cash flow to $260.9 million for the first nine months of 2026, driven by a substantial reduction in inventory levels.

Key figure
Net income $59.2M · -22.6% YoY
9:03 AM ET 8-K
Reverse Stock Split aTYR Pharma INC ATYR

aTYR Pharma Reverse Stock Split

aTyr Pharma filed a Certificate of Amendment to effect a 1-for-40 reverse stock split of its common stock, effective October 28, 2026. The split will reduce the number of outstanding shares from approximately 100.5 million to 2.5 million to meet exchange requirements. Trading on a split-adjusted basis will begin on The Nasdaq Capital Market on October 29, 2026.

9:03 AM ET 8-K
Financial Results Baldwin Insurance Group, Inc. BWIN

Baldwin Insurance Group Financial Results

The Baldwin Insurance Group reported preliminary Q3 2026 financial results, featuring a 31% increase in total revenue to $480.3 million and 47% growth in Adjusted EBITDA. The company also provided an update on its pending all-cash take-private merger with an investor group led by Sequence Holdings and DFO Management, which is expected to close in Q1 2027.

Term
Q3 2026
9:02 AM ET 8-K
Financial Results First Financial Corp THFF

First Financial Financial Results

First Financial Corporation reported record net income of $27.4 million for Q3 2026, up from $20.8 million in the prior year period. The results were driven by strong net interest margin and the impact of the CedarStone Financial acquisition completed earlier in the year. The company also highlighted its pending merger with First Illinois Corporation, which is expected to close in Q1 2027.

Term
Q3 2026

“We are pleased with our third quarter results. The quarter marked another quarter of record net income and record net interest income. Our net interest margin and profitability remain strong with a 4.36% net interest margin and a 1.54% return on assets year-to-date. Loan pipelines remain strong and credit quality remains stable.”

Norman D. Lowery, President and Chief Executive Officer
9:02 AM ET 6-K
Financial Results Biddance AI Systems, Inc. BDAI

Biddance AI Systems H1 2026 Results: Net Loss of $1.37M, Loss Widens

Biddance AI Systems reported a 65% revenue increase to $1.23 million for the first half of 2026, driven primarily by hardware sales. Despite the revenue growth, the company's net loss widened to $1.37 million from $0.92 million in the prior year due to increased general and administrative expenses and lower gross margins.

Key figure
Net loss $1.37M
9:02 AM ET 8-K
Loan & Debt Blackstone Inc. BX

Blackstone Debt Financing Update

Blackstone Inc. announced that its indirect subsidiary, Blackstone Reg Finance Co. L.L.C., intends to offer senior notes in an underwritten public offering. The notes will be fully and unconditionally guaranteed by Blackstone Inc. and several of its holdings subsidiaries, with proceeds intended for general corporate purposes.

9:01 AM ET 8-K
Loan & Debt GeoVax Labs, Inc. GOVX

GeoVax Labs $1M Debt Financing with Bowery Consulting Group Inc.

GeoVax Labs entered into a $1 million unsecured revolving loan agreement with Bowery Consulting Group to fund general corporate purposes and expenses for a planned public equity offering. The facility carries a 12% interest rate and a one-year maturity. In connection with the agreement, five existing directors resigned and three new independent directors nominated by the lender were appointed to the board.

Value
$1M
Counterparty
Bowery Consulting Group Inc.
Term
1 year
9:00 AM ET 8-K
Financial Results Community Financial System, Inc. CBU

Community Financial System Financial Results

Community Financial System, Inc. reported record third-quarter 2026 results, highlighted by operating diluted EPS of $1.27, a 16.5% increase year-over-year. The company also announced a strategic repositioning of its investment portfolio to capture economic value and enhance visibility into future earnings power.

Term
Q3 2026

“Our businesses accelerated into the third quarter and we delivered operating diluted earnings per share of $1.27, up 16.5% year-over-year and 9.5% quarter-over-quarter, representing our sixth consecutive quarter of record results.”

Dimitar A. Karaivanov, President and CEO

“Our trajectory remains intact and we expect strong performance across all of our businesses into the fourth quarter and 2027.”

Dimitar A. Karaivanov, President and CEO
9:00 AM ET 8-K
Business Update TechTarget, Inc. TTGT

TechTarget Business Update

TechTarget provided a preliminary revenue update for the nine-month period ending September 30, 2026, reporting an underlying revenue decline of 1.6% compared to the prior year. The company attributed the decrease to market volatility and enterprise technology customers prioritizing AI investments over marketing and sales support. Full quarterly results under US GAAP are scheduled for release on November 6, 2026.

Counterparty
Informa PLC
Term
9 months
9:00 AM ET 8-K
M&A Deal Pulmatrix, Inc. PULM

Pulmatrix M&A Deal with Eos SENOLYTIX, Inc.

Pulmatrix stockholders approved several key proposals related to its pending merger with Eos SENOLYTIX, Inc., including the issuance of common stock representing more than 20% of the company and a change of control. Stockholders also approved a reverse stock split at a ratio between 1-for-2 and 1-for-10 and an increase in authorized shares to facilitate the transaction. The merger will result in Eos becoming a wholly owned subsidiary of Pulmatrix, forming a combined company.

Counterparty
Eos SENOLYTIX, Inc.
8:56 AM ET 8-K
Business Update Atrium Therapeutics, Inc. RNA

Atrium Therapeutics Business Update

Atrium Therapeutics announced the first patient has been dosed in its Phase 1/2 Corventis clinical trial evaluating ATR 1072 for the treatment of PRKAG2 syndrome. This represents the first interventional clinical trial for this rare genetic cardiomyopathy, with initial proof-of-concept data expected in the second half of 2027.

8:56 AM ET 8-K
Executive Compensation Lifeward Ltd. LFWD

Lifeward Executive Compensation

Lifeward Ltd. appointed Ronen Tsimerman as Chief Financial Officer, effective November 1, 2026. The appointment includes an employment agreement with a gross monthly base salary of NIS 70,000 and a target annual performance-based bonus of at least four monthly salaries, subject to shareholder approval of a renewed compensation policy.

Counterparty
Ronen Tsimerman
8:51 AM ET 8-K
Partnership Aiai Holdings Corp AIAI

Aiai Holdings Partnership with Messier 42 LLC

AIAI Holdings Corporation entered into a Services Agreement with Messier 42 LLC (M42) to jointly establish a War Tech Consortium focused on acquiring and partnering with defense technology companies. AIAI will provide administrative, M&A, and technology services in exchange for a percentage of net proceeds, including 50% of proceeds from an existing anti-drone technology sales agreement. The partnership is projected to generate approximately $125 million in cash for AIAI in 2027 based on the current sales pipeline.

Counterparty
Messier 42 LLC
8:41 AM ET 8-K
Reverse Stock Split Envoy Medical, Inc. COCH

Envoy Medical Reverse Stock Split

Envoy Medical implemented a 1-for-10 reverse stock split of its Class A common stock, effective October 26, 2026. The split is intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing. Every 10 shares of outstanding common stock were automatically combined into one share, with fractional shares settled in cash.

8:36 AM ET 10-K
Financial Results Simply Good Foods Co SMPL

Simply Good Foods FY 2026 Results: Net Loss of $156M

Simply Good Foods Co reported $350 million in outstanding term loan indebtedness as of August 29, 2026, with an undrawn $75 million revolving credit facility. The filing highlights significant regulatory risks regarding FDA labeling for 'net carb' claims and potential liabilities from data security breaches or litigation.

Key figure
Net loss $156M
8:36 AM ET 8-K
Financial Results Itron, Inc. ITRI

Itron Financial Results

Itron, Inc. reported third quarter 2026 revenue of $599 million, a 3% increase year-over-year, driven by growth in its Outcomes and Resiliency Solutions segments. The company achieved record adjusted EBITDA of $115 million and GAAP diluted EPS of $1.61, benefiting from a stronger operating model and expanding software and services portfolio.

Term
Q3 2026

“Itron delivered a strong third quarter, with revenue returning to growth at the top end of our outlook, record adjusted EBITDA, and earnings well ahead of our expectations — demonstrating the earnings leverage of our stronger operating model.”

Tom Deitrich, Itron’s President and CEO

“Utilities’ needs for capacity, reliability, resiliency, and affordability continue to drive demand for our technology, while our expanding software and services portfolio is supporting recurring revenue growth.”

Tom Deitrich, Itron’s President and CEO
8:35 AM ET 8-K
Capital Raise Ellington Credit Co EARN

Ellington Credit Capital Raise

Ellington Credit Company entered into an equity distribution agreement to establish an at-the-market (ATM) offering program for up to $125 million of its common shares. The program allows the Fund to sell shares from time to time through a group of agents including Citizens JMP Securities and B. Riley Securities. Net proceeds are intended for general corporate purposes and to acquire new investments.

Counterparty
Citizens JMP Securities, LLC
8:31 AM ET 8-K
Partnership Securetech Innovations, Inc. SCTH

Securetech Innovations Partnership with QStak Holding, LLC Worth $26.5M

SecureTech Innovations entered into a strategic partnership with QStak Holding involving an exclusive worldwide license for blockchain technology, the formation of a majority-owned joint venture (QStak Market, LLC), and the acquisition of a 15% equity stake in QStak. The total transaction value includes up to $22 million in Series B Preferred Stock for the license and $4.5 million in Series A Preferred Stock for the equity investment.

Value
$26.5M
Counterparty
QStak Holding, LLC
8:31 AM ET 8-K
Contract Win Microbot Medical Inc. MBOT

Microbot Medical Wins Contract from Elmnt Ir

Microbot Medical secured its first Office-Based Laboratory (OBL) customer, ELMNT IR, which signed an order for up to a 12-month supply of the LIBERTY Endovascular Robotic System. This marks the company's first customer on the U.S. West Coast and supports its strategy to expand into outpatient interventional radiology settings.

Counterparty
ELMNT IR
Term
12 months
8:31 AM ET 8-K
Financial Results Esquire Financial Holdings, Inc. ESQ

Esquire Financial Holdings Financial Results

Esquire Financial Holdings reported Q3 2026 net income of $17.5 million, or $1.57 per diluted share, which included the impact of its transformational acquisition of Signature Bancorporation completed on August 1, 2026. On an adjusted basis excluding merger expenses, net income was $23.6 million with an industry-leading adjusted return on average tangible equity of 23.10%.

“This transformational merger enhances our operating profile, expands our resources, and diversifies our balance sheet, bringing together two institutions with highly complementary commercial banking operations and capabilities for continued expansion nationally.”

Andrew C. Sagliocca, Vice Chairman, CEO & President

“Most importantly, the merger unites two highly talented management teams with strong client relationships and market expertise, positioning the combined company for continued industry-leading growth, performance metrics and enhanced success.”

Andrew C. Sagliocca, Vice Chairman, CEO & President
8:30 AM ET 8-K
Business Update Artiva Biotherapeutics, Inc. ARTV

Artiva Biotherapeutics Business Update

Artiva Biotherapeutics is halting all development of its lead cell therapy candidate AlloNK (AB-101) and implementing a 94% workforce reduction after clinical data failed to meet durability thresholds and two patient deaths occurred. The company has engaged Leerink Partners to explore strategic alternatives, including a potential merger, sale, or liquidation, while reporting a preliminary cash balance of $319.1 million.

8:25 AM ET 8-K
M&A Deal GrabAGun Digital Holdings Inc. PEW

GrabAGun Digital Holdings Signs $34M M&A Deal with Camfour Holding, Inc.

GrabAGun Digital Holdings Inc. completed the acquisition of Camfour LLC, a national wholesale distributor of firearms and ammunition, for approximately $34.0 million in cash. The deal integrates Camfour's distribution infrastructure with GrabAGun's AI-driven technology platform to expand its reach into wholesale distribution and improve inventory productivity.

Value
$34M
Counterparty
Camfour Holding, Inc.
8:24 AM ET Form 4
Insider Selling Peoples Bancorp Inc PEBO

Peoples Bancorp EVP, Operations Mark Augenstein Sells $75.8K of Stock

Mark Augenstein, EVP, Operations, sold 2,000 shares of Peoples Bancorp Inc at $37.88 a share, worth $75.8K in total on Oct 23, 2026. Shares held after the trade: 24,885 (-7.4%).

Value
$75.8K
Shares
2,000
Price
$37.88
Role
EVP, Operations
Holding change
-7.4%
Trade date
Oct 23, 2026
8:16 AM ET 8-K
Leadership Change Altimmune, Inc. ALT

Altimmune Leadership Change

Altimmune appointed Peter Greenleaf and Alex Howarth to its Board of Directors effective November 2, 2026, increasing the board size to eleven. As part of a planned transition, directors John M. Gill, Mitchel Sayare, and Klaus O. Schafer will retire at the 2027 Annual Meeting. The new directors will receive an annual cash retainer of $40,000 and initial stock options for 160,000 shares each.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.